Quality and Safety Committee
NYSRS Quality and Safety Committee Report
Shlomit Goldberg-Stein, MD, Victor Scarmato, MD, Hakan Sahin, MD, Ali Noor, MD, Eric Wilck, MD, Nolan Kagetsu, MD, Bari Dane, MD, Peter Rosella, MD, Josh Moosikasuwan, MD
1. Health Equity remains at the forefront of the Radiology conversation, with disparities in care grossly highlighted by COVID-19. As our nation faces continued challenges, most recently with violent hate acts against the Asian American Pacific Islander (AAPI) community, we recognize the work of MGH Radiology in innovating to improve health care disparities. See a recently published ACR Q& S Imaging 3.0 Case Study wherein AI was leveraged to provide translation services using RadTranslate to improve health equity among non-English speakers:
2. “Steerage”: Anthem and Cigna instituted site-of-care imaging steerage polices with guidelines indicating that unless medically necessary, advanced outpatient imaging must be done at freestanding non-hospital affiliated imaging centers for children aged 10 or older. Broad-based advocacy efforts were able to convince United Healthcare to update their criteria and alter their initial policy such that patients under age 19 are automatically permitted to have imaging performed at hospital-based facilities.
3. ACR Dose Index Registry (DIR) allows facilities to compare their CT dose indices to regional and national values. For many years, the DIR only benchmarked CT doses. Now the DIR is adding metrics for fluoroscopy, nuclear medicine/PET, and digital radiography.
4. A webinar on “How to Launch your Peer Learning Program Next Week” took place virtually in March 2021 under the leadership of ACR Peer Learning Committee Chair Dr. Jennifer Broder.
ACR Quality and Safety e news
March 10, 2021
View QPP Webinar to Learn About 2021 Updates
Interested in updates to the Quality Payment Program (QPP) for 2021? Not exactly sure what all the changes entail? A webinar on Year 5 of the QPP for radiologists answers these questions and more.
Dr. Lauren Golding, Chair of the MACRA Committee, and Dr. Richard Heller, Vice-Chair of the MACRA Committee, led the webinar and presented information on:
- Merit-based Incentive Payment System (MIPS) changes;
- Quality measures that have been removed or changed and other category updates (cost, improvement activities, promoting interoperability);
- MIPS Value Pathways and the newly introduced Alternative Payment Model Performance Pathways;
- COVID-19 extreme and uncontrollable circumstances and reporting flexibilities; and
- Big-picture overview surrounding the future of the QPP.
View the QPP webinar for additional information
ACR DSI Webinar on FDA-Cleared AI Algorithms Now Available
A free, on-demand webinar from the artificial intelligence (AI) experts involved in developing the recently released FDA-Cleared Algorithm Catalog from the ACR Data Science Institute® (ACR DSI) shares how to evaluate the 111 commercial algorithms currently available and what to consider in evaluating an algorithm.
- Background on the U.S. Food and Drug Administration (FDA) clearance process and where to find links to the FDA clearance letter for the algorithms listed in the catalog, including background information on risk assessment, device category, use designation and approval pathway.
- An overview of tools developed by ACR DSI for AI performance monitoring, including AI-LAB™ , Certify-AI and Assess-AI .
- Discussion of areas of concern for AI products, such as AI brittleness or robustness.
- Step-by-step guidance on how to use the FDA-Cleared Algorithm Catalog to find algorithms that may be a good fit for your practice.
Lung Cancer Screening Makes Gains As A Detection Tool Many patients already have metastatic disease at diagnosis
March 10, 2021
Lung cancer remains the leading cause of cancer mortality in the United States. Screening for lung cancer can help reduce mortality by detecting cancers at earlier stages when they are more treatable. Lung cancer screening with low-dose CT reduces mortality among high-risk current and former smokers and has been covered by public and private insurers without cost sharing since 2015. The U.S. Preventive Services Task Force (USPSTF) updated its recommendation statement for annual screening for lung cancer with low-dose CT and recommends annual lung cancer screening in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. While patients and referring providers confront numerous barriers to participation in screening, there continues to be an uptick in lung cancer screening participation.
Read recent RSNA News articles on lung cancer screening:
- Social Determinants in Lung Cancer Screening Compliance
- Mammography Patients are an “Untapped Opportunity” to Increase Lung Cancer Screening
- Lung Cancer Screening Images Used to Identify Heart Conditions Read the Radiology commentary, “Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective“.